A detailed history of Msh Capital Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Msh Capital Advisors LLC holds 14,883 shares of JNJ stock, worth $2.32 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
14,883
Previous 9,100 63.55%
Holding current value
$2.32 Million
Previous $1.62 Billion 33.25%
% of portfolio
0.68%
Previous 0.75%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$143.34 - $165.86 $828,935 - $959,168
5,783 Added 63.55%
14,883 $2.15 Billion
Q3 2024

Feb 13, 2025

BUY
$145.48 - $167.38 $12,220 - $14,059
84 Added 0.56%
14,958 $2.42 Billion
Q2 2024

Feb 13, 2025

SELL
$144.38 - $157.78 $89,371 - $97,665
-619 Reduced 4.0%
14,874 $2.17 Billion
Q1 2024

Feb 13, 2025

BUY
$155.22 - $162.74 $9,313 - $9,764
60 Added 0.39%
15,493 $2.45 Billion
Q4 2023

Feb 13, 2025

SELL
$145.6 - $158.88 $149,531 - $163,169
-1,027 Reduced 6.24%
15,433 $2.42 Billion
Q3 2023

Feb 13, 2025

BUY
$155.75 - $174.48 $20,714 - $23,205
133 Added 0.81%
16,460 $2.56 Billion
Q2 2023

Feb 13, 2025

BUY
$154.35 - $166.11 $1.27 Million - $1.37 Million
8,236 Added 101.79%
16,327 $2.7 Billion
Q1 2023

Feb 13, 2025

SELL
$151.05 - $180.26 $5,437 - $6,489
-36 Reduced 0.44%
8,091 $1.25 Billion
Q4 2022

Feb 13, 2025

SELL
$160.2 - $179.79 $164,205 - $184,284
-1,025 Reduced 11.2%
8,127 $1.44 Billion
Q3 2022

Feb 13, 2025

SELL
$161.33 - $179.52 $924,582 - $1.03 Million
-5,731 Reduced 38.51%
9,152 $1.5 Billion
Q2 2022

Feb 13, 2025

BUY
$168.19 - $186.01 $205,696 - $227,490
1,223 Added 15.53%
9,100 $1.62 Billion
Q1 2022

Feb 13, 2025

BUY
$158.14 - $179.59 $152,763 - $173,483
966 Added 13.98%
7,877 $1.4 Billion
Q4 2021

Feb 13, 2025

BUY
$155.93 - $173.01 $1.08 Million - $1.2 Million
6,911 New
6,911 $1.18 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $408B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.